Targeting Musashi-2 to counteract senescence and resistance in chronic myeloid leukemia: enhancing the efficacy of imatinib therapy
Crossref DOI link: https://doi.org/10.1186/s12885-025-15214-5
Published Online: 2025-12-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Arif, Khadija
Yousaf, Maryam
Khan, Dilawar
Text and Data Mining valid from 2025-12-07
Version of Record valid from 2026-01-08
Article History
Received: 28 June 2025
Accepted: 16 October 2025
First Online: 7 December 2025
Declarations
:
: Not applicable.
: The authors declare no competing interests.